Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Support

This activity is supported by an educational grant from Janssen Biotech.

Advances In™: With Many Options, What's Your Approach to Metastatic Castration-Sensitive Prostate Cancer?

Release Date: February 26, 2021
Expiration Date: February 26, 2022

Activity Overview

This online educational activity is designed to provide expert interpretation of new and emerging data on the treatment of metastatic castration-sensitive prostate cancer (mCSPC), with a forward-looking perspective on how novel agents might affect clinical practice. The essentials of clinical trial data, current and emerging treatment strategies, multidisciplinary treatment approaches, and management of treatment-related toxicities will be presented in a multimedia format, including a series of video interviews with an expert thought leader integrated into text-based elements.
 

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Janssen Biotech.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.


Target Audience

This educational program is directed toward urologists interested in the treatment of prostate cancer. Oncologists, nurse practitioners, physician assistants, nurses, and other healthcare professionals involved in the treatment and management of patients with prostate cancer will be invited to participate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Discuss unmet needs in treatment of mCSPC and mechanistic rationale supporting the role of second- generation antiandrogen therapies in this setting
  • Review emerging strategies and data for treatment of patients with mCSPC
  • Devise strategies for optimizing patient selection as well as management of treatment-related adverse events among patients with mCSPC
  • Develop a multidisciplinary care plan for patients with mCSPC to integrate recent advances in current clinical practices

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME guidelines, PER® has identified and resolved all conflicts of interest for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Faculty

Judd W. Moul, MD, FACS
Judd W. Moul, MD, FACS
James H. Semans Professor of Urologic Surgery
Professor of Anesthesiology
Duke University School of Medicine
Division of Urology, Department of Surgery
Duke Cancer Institute
Durham, NC

Disclosures: Grant/Research Support: Pfizer; Consultant: Theralogix, Decipher, Bayer, Myovant, Blue Earth; Speaker’s Bureau: Janssen, Astellas, Dendreon, Pfizer, ExosomeDx, Genomic Health, Sanofi

Celestia S. Higano, MD, FACP
Celestia S. Higano, MD, FACP
Professor, Department of Urologic Sciences
University of British Columbia
Medical Director
Prostate Cancer Supportive Care Program
Vancouver Prostate Centre
Vancouver, BC, Canada

Disclosures: Grant Research Support: Aptevo, Aragon, Astellas, AstraZeneca, Clovis, Dendreon, eFFECTOR Therapeutics, Emergent, Ferring, Genentech, Hoffman-La Roche, Medivation, Pfizer; Advisory Board: Astellas, Bayer, Blue Earth Diagnostics, Clovis, Dendreon, Ferring, Hinova, Janssen, Merck, Orion, Pfizer, Tolmar, Carrick Therapeutics, Novartis, Genentech; Other: Spouse holds stock and former officer of CTI BioPharma

The staff of Physicians’ Education Resource®, LLC (PER®), have no relevant financial relationships with commercial interests to disclose.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.


Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
    123
45678910
11121314151617
18192021222324
252627282930
Filter By